In esophageal cancer, surgery and chemoradiotherapy are standard. In Japan, proton therapy may be evaluated for its precision in protecting the heart and lungs, and photo-immunotherapy as a newer option.
Proton therapy aims to protect critical organs within the chest cavity.
Photo-immunotherapy may be discussed as a light-activated targeted approach in suitable cases.
Minimally invasive surgical techniques are widespread at Japanese centers.
Stage and performance status (nutrition, fitness) determine the treatment plan; the decision belongs to the multidisciplinary board.